• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• O
• Obianom, Obinna
  Johnson and Johnson Innvoative Medicine
• (S-077) Population Pharmacokinetic & Exposure-Response Analysis After Subcutaneous Administration of Guselkumab in Pediatric Participants with Moderate to Severe Plaque Psoriasis
  Obinna Obianom
  Favorite
• Ogami, Chika
  Chugai Pharmaceutical Co., Ltd.
• (S-050) Quantitative systems modeling of inflammation and coagulation abnormalities induced by pathogen infection
  Chika Ogami
  Favorite
• Osawa, Mayu
  Bristol Myers Squibb
• (M-049) Model Platform to Predict Overall Survival for Patients with Relapsed and Refractory Multiple Myeloma
  Mayu Osawa
  Favorite